Form 8-K · Current report
Verisk Analytics 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0001442145
- Accession no.
- 0001437749-26-024748
Summary
Verisk Analytics reported second-quarter 2026 revenue of $806 million, up 4.3% (5.8% on an organic constant-currency basis), with net income of $229 million, down 9.8%, and diluted adjusted EPS of $1.98, up 5.3%. The company reaffirmed its full-year 2026 guidance and said growth should return to Investor Day target levels in the second half; CEO Lee Shavel and CFO Elizabeth Mann attributed the quarter to subscription revenue strength and cost discipline.
Key points
- Net income fell 9.8% to $229 million, which Verisk attributed to a higher effective tax rate, higher net interest expense and legal fees tied to ongoing litigation.
- Adjusted EBITDA rose 4.2% to $464 million, or 7.4% on an organic constant-currency basis.
- Verisk paid a 50-cent quarterly dividend on June 30, 2026, and its board approved another 50-cent dividend payable September 30, 2026.
- Verisk entered a $200 million accelerated share repurchase in the quarter, leaving $800 million under its repurchase authorization.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 29, 2026, Verisk Analytics, Inc. (the “Registrant”) issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is annexed as Exhibit 99.1 and incorporated by reference herein. All information in the press release is furnished but not filed. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated July 29, 2026 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.